porcorex
This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne’s 13F portfolio on a quarterly basis. It is based on Tweedy Browne’s regulatory 13F Form filed on 05/15/2025. Please visit
Tracking Tweedy Browne Portfolio - Q1 2025 Update
Summary
- Tweedy Browne’s 13F portfolio value dropped to $1.13B, with holdings rising to 59; Berkshire Hathaway remains the largest position at 16%.
- Significant trimming occurred in top holdings like Berkshire Hathaway, Alphabet, and Johnson & Johnson, reflecting a strategy of harvesting long-term gains.
- The fund continues its value investing approach, with concentrated bets in CNH Industrial, Coca-Cola FEMSA, and Ionis Pharma, despite recent portfolio reductions.
- Tweedy Browne’s disciplined rebalancing and global orientation underscore its commitment to value investing principles and prudent risk management.
Focused on analyzing 13F reports & building tools to help DIY investors generate absolute returns through exploiting inefficiency, volatility, and momentum. Broader commentary for DIY investors at https://diyabsolutereturns.substack.com/
Analyst’s Disclosure:I/we have a beneficial long position in the shares of GOOGL, UHAL.B either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.